Podcasts about hcps

Since podcasting came into existence in the mid-2000s, the space has become increasingly popular, remarkably lucrative and unquestionably saturated. Still, despite the countless millions of podcasts out there, countless millions of people tune in every hour of every day for conversations about every topic – including healthcare.  Joining a world occupied by This Past Weekend, Good Hang and The MM+M Podcast is The Persistence Lab. Launched by AbbVie's corporate affairs team, The Persistence Lab is the pharma giant's 10-episode project to highlight the work undertaken by its researchers, the clinical expertise of HCPs as well as the lived experiences of patients.  The first episode of The Persistence Lab was released late last week and is available wherever you listen to your podcasts.Molly James-Lundak, VP of R&D communications at AbbVie, joined me for a slightly meta conversation about joining the podcast sphere, how the drugmaker brought the idea to life and why it was important to engage with audio content creation.   And for our Trends segment, we're talking about AI in healthcare: Including the tools that actually work, the regulations on the way and the concerns that never go away.  Music: “Deep Reflection” by DP and Triple Scoop Music.   Check us out at: mmm-online.com Follow us: YouTube: @MMM-onlineTikTok: @MMMnewsInstagram: @MMMnewsonlineTwitter/X: @MMMnewsLinkedIn: MM+M To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.Music: “Deep Reflection” by DP and Triple Scoop Music. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: big updates for stem cell and islet transplants, new pen option for Zepbound, an implantable insulin pump moves forward and more! Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  T1D Screening info All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Episode transcription with links: Welcome! I'm your host Stacey Simms and this is an In The News episode.. where we bringing you the top diabetes stories and headlines happening now. A reminder that you can find the sources and links and a transcript and more info for every story mentioned here in the show notes. Quick reminder: I'm just back from MNO DC and I'm exhausted. But it's the best kind of tired. We had an incredible time – hope you can join us in Nashville. With a reminder that we have our first Club 1921 in Nashville – that's our educational dinner series for HCPs and patient leaders. All the info is over at diabetes-connections.com events/     Okay.. our top story this week: XX An "immune system reset" eliminated Type 1, diabetes in mice in a study conducted at Stanford Medicine without immune suppressant medications. This was a combined transplant of blood stem cells and insulin-producing pancreatic islet cells from a donor whose immune profile did not match the recipient. The dual transplant approach both restored insulin production and retrained the immune system. For the full six months of the experiment, the animals did not need insulin injections or immune suppressive medications. Challenges remain using this approach to treat Type 1 diabetes. Pancreatic islets can be obtained only after death of the donor, and the blood stem cells must come from the same person as the islets. It is also unclear whether the number of islet cells typically isolated from one donor would be enough to reverse established Type 1 diabetes. But the researchers are working on solutions, which could include generating large numbers of islet cells in the laboratory from pluripotent human stem cells, or finding ways to increase the function and survival of transplanted donor islet cells. https://scitechdaily.com/stanford-scientists-cure-type-1-diabetes-in-mice-without-insulin-or-immune-suppression/ XX An electronic implant interlaced with islet cells is being looked at to treat type 1. Researchers at the University of Pennsylvania School of Medicine worked with engineers at Harvard University to combine stem-cell biology with soft electronics. They inserted an ultrathin, flexible mesh of conductive wires — thinner than a human hair — into developing pancreatic tissue. As the cells assembled into clusters, the mesh became woven through them. The electronics can record the faint electrical signals produced by the cells that control insulin release. They can also deliver small pulses of electricity back to the cells.   After several days, the cells began to behave more like mature islets. Their internal signalling shifted, neighbouring cells started working in concert and insulin release became stronger and better timed.  Very early on here – and the transplanted cells still need to be protected from being attacked by the immune system. https://www.thetimes.com/uk/science/article/first-cyborg-pancreas-implants-type-1-diabetes-nxkv8r0fp?gaa_at=eafs&gaa_n=AWEtsqeJYYUF9TMR-GgGUG92hPyog-ISeiqGIgdyaaIKKcpvhtoftGiUaaOtQeG0NWI%3D&gaa_ts=699c50d4&gaa_sig=w-PQ0ArosZSznYDSWEzt8aQg4WC0FF5ZFRt9NedO5sSTL2FyWzupH8eSG7RCy2S8TQnlHOeKCudANWm1MNI59w%3D%3D XX Katie Beth (hand) Eledon trial – aaron kowalski post linkedin. Last fall we told you about promising results from Eledon's drug to prevent islet transplantation rejection in type 1 diabetes. The first six patients no longer had to inject or infuse insulin.. the trials continue and this month one of the patients – Katie Beth Hand – began posting about her experiences one month in, on social media, she says she's off basal insulin already and in range 99 percent of the time. She is also encouraging people to learn more about support the islet act https://lnkd.in/e8pQ7_Y7 XX This is a bill introduced last November which would change the wording on pancreatic cell transplants. The problem is that islets are classified as drugs rather than organs, making transplantations difficult for medical teams and centers to preform due to accessibility. Insurance companies are also less likely to provide reimbursements for treatment, which can cost hundreds of thousands of dollars. The official Journal of The Transplantation Society estimates the cost at about $140,000. The bill went to the senate committee of Health, Education, Labor, and Pensions in early November. No other action has been taken since then. https://www.wtoc.com/2026/02/19/bluffton-family-advocates-islet-act-help-diabetic-son/ XX Big change for the obesity drug Zepbound – now available in the multi dose KwikPen. This is a month's worth of doses in a single pen.. and it's multi dose – you can adjust it. Cash-paying patients can get the multi-dose device, called KwikPen, on the company's direct-to-consumer website, LillyDirect. Prices start at $299 per month for the lowest dose level. Until now, you could only get zepbound in a single dose auto injector or a sing dose vial. In a release, Lilly said the Food and Drug Administration approved a label expansion for Zepbound to include the multi-dose device. The KwikPen is already used for other drugs, such as Lilly's popular diabetes medication, Mounjaro – which is the same medication as zepbound, they're both tirzepitide. https://www.cnbc.com/2026/02/23/eli-lilly-launches-zepbound-obesity-drug-pen-one-month-doses.html   XX For years, researchers have observed that people who live at high elevations,  tend to develop diabetes less often than those at sea level. Although the trend was well documented, the biological explanation behind it was unclear. Scientists now say they have identified the reason. Their research shows that in low oxygen environments, red blood cells begin absorbing large amounts of glucose from the bloodstream. Their work showed that when oxygen is limited, red blood cells use glucose to generate a molecule that helps release oxygen to tissues. This process becomes especially important when oxygen is in short supply. The researchers also found that the metabolic benefits of prolonged hypoxia lasted for weeks to months after mice were returned to normal oxygen levels. They then evaluated HypoxyStat, a drug recently developed in Jain's lab that mimics low oxygen exposure. HypoxyStat is taken as a pill and works by causing hemoglobin in red blood cells to bind oxygen more tightly, limiting the amount delivered to tissues. In mouse models of diabetes, the medication completely reversed high blood sugar and outperformed existing treatments. https://www.sciencedaily.com/releases/2026/02/260221060952.htm XX Watching this one closely – Portal Diabetes gets FDA breakthrough device designation for its implantable insulin pump system. This is a system that includes not just a device that's implanted into the abdomen, but also a new, temperature stable insulin. It will work with – quote – "modern" CGM technology with a fully closed loop - and aims to deliver a functional cure for type 1. While reports say Portal's system is the first in the US – there was an implantable pump developed and used by about 500 people worldwide, including about 100 in the US – by MiniMed. Medtronic bought the company and in 2007 they stopped that program. Portal Diabetes expects to begin clinical trials on its combination system around the fourth quarter of 2027. https://www.drugdeliverybusiness.com/portal-diabetes-fda-breakthrough-implantable-insulin-pump/ XX Sequel Med Tech and Senseonics (NYSE:SENS) today announced the full U.S. launch of their CGM and insulin pump integration. That's the eversense cgm and twist pump. Sequel said its full launch with Eversense 365 makes twiist available with two compatible CGMs. twiist also pairs with the Abbott FreeStyle Libre 3 Plus sensor. Eversense 365, an implantable system, rests under the skin for the duration of a year. Users can change its external, silicone-based adhesive daily with almost no skin reactions. https://www.drugdeliverybusiness.com/sequel-senseonics-full-launch-twiist-eversense/ XX Right back with a Dexcom update, and a look at which type of diet reduces insulin use overall.. right after this: -- Back to the news.. Dexcom is watching for expanded Medicare coverage of its continuous glucose monitors to people with Type 2 diabetes who don't take insulin. CEO Jake Leach told investors on Thursday that the company has been "sitting here waiting for a coverage decision" from the Centers for Medicare and Medicaid Services Dexcom started to see commercial coverage unlock for Type 2, non-insulin users toward the end of last year, Leach said. He expects broader Medicare coverage for that group would allow nearly 12 million people to access CGMs.     In the meantime, the American Diabetes Association updated its guidelines last year to recommend clinicians consider using CGMs for Type 2 diabetes when patients are taking glucose-lowering medications other than insulin. Leach said that real world data the company has been generating supports that decision, and that Dexcom has launched a registry for non-insulin users. https://www.medtechdive.com/news/dexcom-seeks-expanded-medicare-coverage-of-cgms-for-type-2-diabetes/812223/ XX Medtronic's separation of MiniMed is not yet complete.. but continues to move forward. The company has submitted their next pump – MiniMed Flex – to the FDA. This is a pump smaller than the 780G but uses the same reservoirs and infusion sets. It will also work with both the Simplera Sync and Instinct sensors. Medtronic also began a U.S. pivotal study for Vivera, its third-generation algorithm for automated insulin delivery. It also remains set to submit its MiniMed Fit patch pump system to the FDA by the coming fall. https://www.drugdeliverybusiness.com/medtronic-submits-minimed-flex-fda-q3/ XX A study modelling how genes may influence a child's body mass index over time has found that BMI at age 10 and overall growth rate between ages one and 18 might be important factors, as the two are more likely linked to diabetes, high cholesterol, and heart disease in later life. Nearly 66,000 BMI measurements from around 6,300 children and adolescents aged one to 18 were analysed to understand the role of genes.     "Future research is needed to help identify the most effective ages to prevent obesity or poor growth for long-term benefit." https://www.ndtv.com/health/bmi-at-age-10-growth-rate-up-to-age-18-are-important-factors-for-diabetes-heart-disease-study-11125146 XX A low-fat vegan diet—without cutting calories or carbs—may help people with type 1 diabetes significantly reduce how much insulin they need. In a new analysis published in BMC Nutrition, participants following the plant-based plan lowered their daily insulin use by 28%, while those on a portion-controlled diet saw no meaningful change. Researchers say the reduced insulin requirement likely reflects improved insulin sensitivity. The original 2024 study reported additional benefits from the vegan diet. Participants lost an average of 11 pounds and showed improvements in insulin sensitivity and glycemic control. Cholesterol levels and kidney function also improved among those following the plant-based plan. https://www.sciencedaily.com/releases/2026/02/260212234212.htm XX Interesting little tidbit from the Winter Olympic Games.. the World Anti-Doping Agency (WADA) was monitoring GLP drug use. An advisory group that makes recommendations about WADA's list of prohibited substances discussed the status of GLP-1 medications, and added semaglutide (Ozempic, Wegovy, Rybelsus) and tirzepatide (Mounjaro, Zepbound) to its monitoring program That means patterns of use of these drugs will be tracked both in and out of competition.  The finding will be used to make recommendations about whether GLP-1 agonists should be added to the prohibited list, the spokesperson explained. While GLP-1 drug use is not currently prohibited, that could change before the next Summer Olympic Games in Los Angeles in 2028, he noted. https://www.medpagetoday.com/popmedicine/cultureclinic/119770 XX That's it for in the news!

The term "omnichannel engagement" has become embedded in today's healthcare conversations. Yet the biopharmaceutical industry often approaches it superficially – treating it as a trendy buzzword instead of a meaningful strategy for connecting with the sector's two most vital audiences: patients and healthcare providers (HCPs). In this episode of the pharmaphorum podcast, developed in partnership with Reverba Global, editor-in-chief Jonah Comstock sits down with Cheryl Lubbert, co-founder and CEO of Reverba Global, and Carolyn Whiting, SVP of clinical and medical client services, to discuss how a thoughtfully executed omnichannel strategy can empower scientific experts to become effective communicators. Today's patients actively seek scientifically robust, yet accessible, information about their health conditions, and a well-integrated medical affairs strategy can help deliver that knowledge through the HCPs they trust most. However, bringing this vision to life requires forward-thinking strategies that build authentic connections, challenge conventional approaches, and dismantle the communication silos that frequently exist in healthcare organisations. Throughout the episode, Lubbert and Whiting share Reverba Global's methodology for authentic omnichannel engagement with patients and physicians, offering real-world examples and practical perspectives on navigating obstacles and establishing this evolved model. You can listen to this episode of the pharmaphorum podcast using the player below, download the episode to your computer, or find it - and subscribe to the rest of the series – on Apple Podcasts, Spotify, Overcast, Pocket Casts, Podbean, and pretty much wherever else you download your other podcasts from.

Children can experience illnesses and will often encounter procedures which can cause pain when they attend or are admitted to hospital. This experienced pain may be acute, chronic and/or persistent in nature. National and International guidelines are available directing Healthcare practitioners (HCPs) on how to assess and manage pain. Despite this, the assessment and management of children's pain remains a challenge within healthcare teams, and the burden of pain in children, and its impact on families and society is significant (Eccleston et al., 2021). So, let's shine a light on pain across our healthcare curriculums and in our healthcare settings to ensure that our patients get the best possible, evidence-based care and avoid the fear and lack of confidence that their pain will be managed appropriately. We have a responsibility to review our education provision to ensure that specified content is included, we need to call for improved CPD funding for staff and we need to increase awareness within the healthcare setting of the short- and long-term impact of untreated pain in children.

Chelsey Winegar, LCSW, MBA, Intermountain Health, Murray, UT Recorded on January 8, 2026 Chelsey Winegar, LCSW, MBA Manager of Oncology Services Intermountain Health Murray, UT Join Chelsey Winegar, LCSW and Manager of Oncology Services at Intermountain Health in Murray, UT, as she breaks down the key differences between burnout and compassion fatigue, and why understanding both is essential for the well being of healthcare professionals and the patients they serve. Chelsey shares practical strategies for recognizing early warning signs, monitoring staff wellness, and building supportive, stigma free environments. The episode also highlights resources and education to help clinicians maintain resilience in demanding clinical settings. Listen in to learn more today! Mentioned on this episode: Trauma Stewardship Additional Blood Cancer United Resources: Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education Blood Cancer United Resources for Patients

In this episode of the IRH Clinician's Corner, IRH lead practitioner Sara Fields sits down with Star Edwards, Healthcare Practice Director at Tiny Health, for an enlightening conversation about the evolution of gut health diagnostics—especially in pediatrics, but with insights spanning all ages. From understanding key differences between pediatric and adult microbiomes to exploring innovative metrics like HMO digestion and inflammatory markers, Sara Fields and Star Edwards make this complex data approachable, actionable, and relevant.   In this interview, we discuss:   The origins of Tiny Health and what sets them apart from other microbiome testing The importance of first 1,000 days for immune and neurodevelopment Tiny Health's suite of tests Comparing whole genome sequencing to other methods of testing (like PCR) Key results categories/metrics and examples of markers unique to Tiny Health Clinical applications and insights The Clinician's Corner is brought to you by the Institute of Restorative Health. Follow us: https://www.instagram.com/instituteofrestorativehealth/   Connect with Star Edwards/Tiny Health: Website: https://www.poweredbytiny.com/ LinkedIn: https://www.linkedin.com/in/star-edwards/   For practitioners looking to open an account with Tiny Health and order test kits, go to https://www.poweredbytiny.com/practitioners   Use discount code IRH2025 to receive $50 off your first Gut Health or PRO Gut Health test  For more resources, including sample reports, research, report walkthroughs, and interpretation guides: https://www.poweredbytiny.com/resources   Timestamps:  00:00 Passion for Microbiome and Nutrition 09:06 "Microbiome's Role in Early Development" 11:36 HMO Digestion and Infant Health 20:23 "Functions: The Frontier of Microbiome" 21:32 Microbiome Functions and Health Connections 30:00 Microbiome Patterns and Health Insights 34:36 Microbiome Differences Across Ages 42:08 "LPS: Gut Inflammation Explained" 47:59 "Tiny Health's Key Insights" 50:03 Microbiome Balance Through Testing 58:40 "H. Pylori Testing Advice" 01:02:02 Personalized Microbiome Testing Benefits Speaker bio:  Star is a former WIC high-risk dietitian and has helped her own clients in private practice, focused on food allergies and sensitivities, gastrointestinal conditions, athletic performance, and pediatrics. For much of her career, she has worked for food allergy and microbiome testing companies, training and mentoring health care practitioners on test interpretation and microbiome recovery protocols. As the Healthcare Practice Director of Tiny Health, she works closely with HCPs to assure Tiny Health testing is actionable and helps them solve their patient microbiome grievances.   Keywords:  functional health, microbiome testing, Tiny Health, gut microbiome, pediatrics, food allergies, eczema, atopic march, C-section birth, whole genome sequencing, stool chemistry, probiotics, dietary recommendations, immune system, chronic disease, practitioner resources, reference ranges, short chain fatty acids, HMO digesting species, LPS (lipopolysaccharide), TMA (trimethylamine), neurodevelopment, inflammation, GI health, diversity in microbiome, beneficial microbes, disruptives/pathogens, action plan, clinical insights, gut-brain connection Disclaimer: The views expressed in the IRH Clinician's Corner series are those of the individual speakers and interviewees, and do not necessarily reflect the views of the Institute of Restorative Health, LLC. The Institute of Restorative Health, LLC does not specifically endorse or approve of any of the information or opinions expressed in the IRH Clinician's Corner series. The information and opinions expressed in the IRH Clinician's Corner series are for educational purposes only and should not be construed as medical advice. If you have any medical concerns, please consult with a qualified healthcare professional. The Institute of Restorative Health, LLC is not liable for any damages or injuries that may result from the use of the information or opinions expressed in the IRH Clinician's Corner series. By viewing or listening to this information, you agree to hold the Institute of Restorative Health, LLC harmless from any and all claims, demands, and causes of action arising out of or in connection with your participation. Thank you for your understanding.  

Our 74th episode features a detailed and comprehensive discussion with Dr. I David Daniels on the unique risk factors found in Healthcare, Public Sector operations, and more and how these risks include Psychosocial factors and necessary risk controls. Thank you to Dr. Daniels for his return to the show and insights based on his experience, research and publications.

Michael J. Mauro, MD, Memorial Sloan Kettering Cancer Center, New York, NY Recorded on October 23, 2025 Michael J. Mauro, MD Director, Chronic Myeloid Leukemia Program Professor of Medicine, Leukemia Service Memorial Sloan Kettering Cancer Center New York, NY Tune in for this expert-led discussion with Dr. Michael Mauro from Memorial Sloan Kettering Cancer Center […]

In our lighter 73rd episode, Cory and return guest Tim Guerinot test Cory's old hypothesis from him previous published articles that Safety Management for him was actually learned from their punk rock band long before formal education

Our 72nd episode features a great conversation with Wendy Stephenson, our current HCPS Assistant Administrator, on what she would tell her younger self about a career in safety after decades of learning experiences on the job, also known as "Things we wish we knew back then." Thanks, Wendy!

As Gen Z steps into the healthcare workforce, they're bringing new expectations for authenticity, technology, and purpose-driven brands. The old pharma playbook? Invisible to this generation.In this episode of Trending Health, host Adrea Cope sits down with Carolyn Frantz and Mindy McGrath to explore how life sciences marketers can evolve to engage the next generation of HCPs and patients — from short-form content and streaming-first strategies to redefining the pharma rep of the future.To learn more about how we can help your team navigate these changing landscapes, please reach out to Carolyn.Frantz@vynamic.com or Mike.Zapiec@vynamic.comPodcast Tags: healthcare, life sciences, life sciences marketing, Gen Z, digital health, brand authenticitySource Links:Gen Z more likely to report mental health concernsGeneration X Faces Higher Cancer Rates Than Boomers: StudyPanel – Adrea Cope, Carolyn Frantz, Mindy McGrathResearch & Production – Adrea Cope, Carolyn Frantz, Hannah Yee, Mike ZapiecRecording & Editing – Mike Liberto, Rachel SkoneckiFor additional discussion, please contact us at TrendingHealth.com.

A new limited series of the Syneos Health Podcast, Conversations on Commercialization unpacks how biopharma leaders are rewriting the commercial playbook, redefining what it takes to succeed.  Recorded at Fierce Pharma Week 2025, the series begins with a two-part conversation with Mark Bard, co-founder of the Digital Health Coalition. In this episode, Bard joins host Tyler Cowan, VP, Commercial at Syneos Health to unpack how the pandemic reshaped provider expectations and the continued impact on commercial teams. From feedback loops to content fatigue, to the myth of multichannel mastery, they break down what it takes to engage HCPs on their terms. The views expressed in this podcast belong solely to the speakers and do not represent those of their organization. If you want access to more future-focused, actionable insights to help biopharmaceutical companies better execute and succeed in a constantly evolving environment, visit the Syneos Health Insights Hub. The perspectives you'll find there are driven by dynamic research and crafted by subject matter experts focused on real answers to help guide decision-making and investment. You can find it all at https://www.syneoshealth.com/insights-hub. Like what you're hearing? Be sure to rate and review us! We want to hear from you! If there's a topic you'd like us to cover on a future episode, contact us at podcast@syneoshealth.com.

Medical marketing is faced with gale-force winds of uncertainty, so we're going to spend most of this week's episode focused on the industry's future but in two distinct ways.For our feature interview, we're joined by recurring guest Andrea Palmer, the CEO of Publicis Health Media, as well as Brad Liebow, who recently jumped from Spark Foundry to become PHM's first chief investment officer.The pair explain why the position was established, how it is designed to further differentiate PHM from other medical marketing agencies and how they assess the modern health media landscape.After that is our Trends segment, where we'll discuss the Trump administration's press conference tying the usage of Tylenol among pregnant women to the rise in cases of autism.The announcement, while widely-expected, was presented to the American people without solid evidence – so we'll dive into what it all means for health brands like Tylenol manufacturer Kenvue as well as medical marketers and HCPs.We'll also do a bit of housecleaning on those Untitled Letters from the FDA as part of the ongoing DTC pharma ad crackdown. Music: “Deep Reflection” by DP and Triple Scoop Music. Step into the future of health media at the MM+M Media Summit on October 30th, 2025 live in NYC! Join top voices in pharma marketing for a full day of forward-thinking discussions on AI, streaming, retail media, and more. Explore the latest in omnichannel strategy, personalization, media trust, and data privacy—all under one roof. Don't wait—use promo code PODCAST for $100 off your individual ticket. Click here to register! AI Deciphered is back—live in New York City this November 13th.Join leaders from brands, agencies, and platforms for a future-focused conversation on how AI is transforming media, marketing, and the retail experience. Ready to future-proof your strategy? Secure your spot now at aidecipheredsummit.com. Use code POD at check out for $100 your ticket! Check us out at: mmm-online.com Follow us: YouTube: @MMM-onlineTikTok: @MMMnewsInstagram: @MMMnewsonlineTwitter/X: @MMMnewsLinkedIn: MM+M To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.Music: “Deep Reflection” by DP and Triple Scoop Music. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Content curated for dermatologists and skin deep HCPs – on Psoriasis, CLE, vasculitis, HS and dermatology drugs use, efficacy and side effects and more.  Features Dr. Jack Cush, Editor at RheumNow.com. SHOW NOTES: 1. SMILE Study: A randomized, placebo-controlled trial of hydroxychloroquine in incomplete lupus  https://t.co/NnrA8ohiGX 2. Equal Safety of JAK Inhibitors and TNF Inhibitors in H2H IMID trials JAMA systematic review.  https://t.co/HI1KBKZiXR 3. SMART study - Single vs. Split Dose Methotrexate  https://t.co/lizsrtVHwf 4. Vegan diets don't work in RA - Metanalysis of 7 studies https://t.co/jeh6gN5Byg 5. No association between IL-17 inhibitors & MACEs (vs TNFi Rx)  https://t.co/fJuPFYKnSr https://t.co/Vscnsq0DTA 6. Successful Phase 3 UP-AA Trial evaluating Upadacitinib in Alopecia Areata (AA) https://t.co/8p1FvJx0s0 7. Anifrolumab effective & safe in refractory Cutaneous LE - OL Study in 15 CLE https://t.co/umEYz0XDyt 8. "Never doubt that a small group of thoughtful, committed citizens can change the world; indeed, it's the only thing that ever has." - Margaret Mead https://t.co/OFGN223bPa

Frontiers Health is back, and celebrating 10 years of innovation, conversation, and collaboration.   In this episode of our Frontiers Health limited series of the pharmaphorum podcast, Deep Dive editor Eloise McLennan speaks with Denise Silber, founder of Basil Strategies and Doctors 2.0.   Having spent more than two decades working at the intersection of healthcare professionals, patients, and technology, Silber has had a front row seat to the evolution of digital tools in the sector. From the early adoption of electronic health records to the integration of new artificial intelligence, she has witnessed dramatic shifts across life sciences, yet at the heart of her work remains the core focus of patient centricity.   In this interview, she discusses the importance of spotlighting patient centricity at Frontiers Health, what makes the event special, and her favourite moments from years gone by.  

Explore the latest trends in HCP content consumption and how pharma marketers can adapt their strategies to reach their target audience effectively with The Trade Desk's senior director of business development Lindsay Reardon and Swoop's VP of client success Kevin Elwell. They will share research insights into how HCPs engage online, highlighting the growing importance of CTV and audio channels, how a data-driven approach can break down silos between HCP and DTC campaigns and how to elevate patient and HCP engagement strategies. Step into the future of health media at the MM+M Media Summit on October 30th, 2025 live in NYC! Join top voices in pharma marketing for a full day of forward-thinking discussions on AI, streaming, retail media, and more. Explore the latest in omnichannel strategy, personalization, media trust, and data privacy—all under one roof. Don't wait—use promo code PODCAST for $100 off your individual ticket. Click here to register! AI Deciphered is back—live in New York City this November 13th.Join leaders from brands, agencies, and platforms for a future-focused conversation on how AI is transforming media, marketing, and the retail experience. Ready to future-proof your strategy? Secure your spot now at aidecipheredsummit.com. Use code POD at check out for $100 your ticket! Check us out at: mmm-online.com Follow us: YouTube: @MMM-onlineTikTok: @MMMnewsInstagram: @MMMnewsonlineTwitter/X: @MMMnewsLinkedIn: MM+M To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.Music: “Deep Reflection” by DP and Triple Scoop Music.

Content curated for dermatologists and skin deep HCPs – on Psoriasis, CLE, vasculitis, HS and dermatology drugs use, efficacy and side effects and more. Features Dr. Jack Cush, Editor at RheumNow.com.

In Breaking the Code's 50th episode, we are joined by our 2025 summer intern, Gabriel Robinson (GR), not to be confused with Gabriel Allen-Cummings (GA). This conversation began because of GR's curiosity about social media being used for self-diagnosis, and it evolved to cover HCPs on social media, generational nuances in social media use, and the emergence of AI as a comprehensive caregiver.Follow us on LinkedIn

Send us a textDr. Duplantis and Dr. Horowitz are holding down the fort this week by bringing you answers to all the burning questions you have about what goes into hiring an associate at your dental practice. From pre-hire preparation to planning a seamless onboarding process, the DINKs have you covered!

Resources for the Community:___________________________________________________________________https://linktr.ee/theplussidezpodcast Ro - Telehealth for GLP1 weight management https://ro.co/weight-loss/?utm_source=plussidez&utm_medium=partnership&utm_campaign=comms_yt&utm_content=45497&utm_term=55Find Your US Representatives https://www.usa.gov/elected-officials ______________________________________________________________________Continuing our vital conversation from GLP-1s & Men's Health: Jhon Henri's Weight Loss Story P1, we welcome Dr. Catherine Toomer an expert on weight management, who offers her insights on weight, health, and metabolic well-being. Building on Jhon Henri's powerful story and how GLP1s changed his life, Dr. Toomer unpacks the complexities of obesity as a disease, the limitations of BMI, and why the focus should shift from simple weight loss to metabolic correction.Discover why societal views on weight, particularly for men, contribute to healthcare disparities, and how GLP-1 medications work beyond "food noise" to address underlying metabolic issues. Dr. Toomer also sheds light on the often-misunderstood connection between rapid weight loss and gallstones, and candidly discusses the physiological changes women experience during perimenopause and menopause, including the role of estrogen decline in weight gain.This episode is a must-listen for anyone seeking a deeper understanding of chronic weight management, the importance of advocating for your health, and the journey toward holistic well-being.______________________________________________________________________⭐️Mounjaro Stanley⭐️griffintumblerco.Etsy.comUse code PODCAST10 for $ OFF______________________________________________________________________Join this channel to get access to perks:   / @theplussidez____________________________Send us Fan Mail!Diabetes dialogues podcastDiabetes insights for HCPs. Dexcom's expert-led podcast, Diabetes Dialogues.Listen on: Apple Podcasts SpotifySupport the showKim Carlos, Executive Producer TikTok https://www.tiktok.com/@dmfkim?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/dmfkimonmounjaro?igsh=aDF6dnlmbHBoYmJn&utm_source=qr Kat Carter, Associate Producer TikTok https://www.tiktok.com/@katcarter7?is_from_webapp=1&sender_device=pc Instagram https://www.instagram.com/mrskatcarter?utm_source=ig_web_button_share_sheet&igsh=ZDNlZDc0MzIxNw==

Empowerment and Success Against the Odds: Kelsey Lewis' Journey with DiabetesIn this episode of The Pediatric Lounge podcast, hosts George and his co-host welcome Kelsey Lewis, a registered dietitian and certified diabetes care specialist. Diagnosed with type 1 diabetes at 17, Kelsey turned her personal challenges into a professional mission. She shares her journey from being told she couldn't be a collegiate athlete to proving her doubters wrong. After her clinic was shut down due to financial priorities, Kelsey established a thriving private practice that now serves 23 states through telemedicine. Her resilient story underlines the importance of not letting others define your limits, the transformative power of education, and the need for independent practices to prioritize patient outcomes over profitability.00:00 Introduction to The Pediatric Lounge00:37 Meet Kelsey Lewis: A Journey from Athlete to Diabetes Specialist01:28 Kelsey's Diagnosis and Early Challenges02:52 Overcoming Obstacles: From High School to College Athlete11:17 Transition to Professional Life and Systemic Challenges23:50 Establishing a Private Practice and Expanding Nationwide27:47 Telemedicine Success and Future Prospects28:53 Lessons in Resilience and Overcoming Adversity30:45 Partnering with Medical Practices for Better Outcomes35:26 Challenges and Advocacy in Pediatrics40:30 The Impact of Sugar and Salt on Health49:32 Final Thoughts and Advice for ParentsYou can connect with Kelsie here. Diabetes dialogues podcastDiabetes insights for HCPs. Dexcom's expert-led podcast, Diabetes Dialogues.Listen on: Apple Podcasts SpotifySupport the show

Send us a message with this link, we would love to hear from you. Standard message rates may apply.We break down the key differences between Tylenol (acetaminophen) and NSAIDs (ibuprofen, naproxen, aspirin) to help you make informed decisions about which pain reliever is right for you. This evidence-based discussion draws from top medical sources to explain how these common medications work differently in your body.• Tylenol works on perception of pain and fever in the brain but doesn't address inflammation• NSAIDs reduce pain, fever AND inflammation by blocking the prostaglandin cascade• Both medications are commonly used for everyday pain including headaches and general discomfort• NSAIDs are usually more effective for inflammatory conditions like sprains, arthritis, and period cramps• Tylenol's main risk is liver damage at high doses (max 4,000mg daily for most adults)• NSAIDs can cause stomach ulcers, GI bleeding, increased blood pressure, and kidney problems• Consider your medical history when choosing—liver issues (caution with Tylenol), stomach/heart/kidney problems (caution with NSAIDs)• Age is a factor—older adults generally face higher risks with NSAIDs• Taking NSAIDs with food can help reduce stomach problems• Always read labels and follow dosing instructions carefullyShare this episode with friends or family who take these medications regularly to help them understand what they're putting in their bodies.Diabetes dialogues podcastDiabetes insights for HCPs. Dexcom's expert-led podcast, Diabetes Dialogues.Listen on: Apple Podcasts SpotifySupport the showSubscribe to Our Newsletter! Production and Content: Edward Delesky, MD & Nicole Aruffo, RNArtwork: Olivia Pawlowski

Send me a message - text me! Last night, a trip to a familiar venue for my weekly pool match brought back a memory I hadn't felt in years. I was ten years old, dancing in front of a mirror in the toilets, completely lost in joy. I wasn't worrying about my body. I wasn't thinking about food. I was just happy.In this episode, I share what it felt like to reconnect with that version of me, and how soon after diet culture crept in and began to change everything. This is a personal and emotional reflection on body image, childhood innocence, and the moment things started to shift.I talk about what I'd say to my younger self now, how we can all learn from those early memories, and what it means to heal the relationship with your body and reclaim the joy that was once yours.Whether you've lost touch with your younger self or you're working on healing your body image, this episode is a gentle reminder that she's still in there. She always was. Maybe she just needs a little coaxing back out.

Send us a textDo you struggle with sleep issues like sleep apnea or bruxism? Your dentist is going to want to know about it. There is a huge connection between our dental health and sleep quality that can affect long-term overall health. Sometimes the dentist is the first person to observe a patient has sleep issues.  In this episode, the DINKs take a deep dive in structural and health issues that could be affecting the way you sleep at night!Tune in to this patient-focused episode to learn:  The connection between sleep disorders and dental issuesWhat you should expect from a conversation about sleep with your dentist Everything you should look for if you suspect your oral health may be affecting your sleep

Rural Pediatrics: A Conversation with Dr. Eric TylerIn this episode of The Pediatric Lounge, hosts George and Herb welcome Dr. Eric Tyler, a seasoned pediatrician with over 40 years of experience in rural Alabama. Dr. Tyler shares his journey into pediatrics, inspired by his childhood experiences and his work ethic instilled by his farming upbringing. He discusses the unique challenges and rewards of practicing pediatrics in a rural setting, addressing the impact of adverse childhood experiences and the importance of community engagement. Dr. Tyler emphasizes the need for systemic changes in healthcare funding and education to better support rural pediatricians and their patients. He also shares innovative community initiatives aimed at improving children's health and well-being, including a meditation program for local schools and telehealth services for mental health. The conversation underscores the importance of rethinking dogma in medical practice to better meet the needs of underserved populations.00:00 Introduction to The Pediatric Lounge00:28 Meet Dr. Eric Tyler: A Rural Pediatrician01:22 Dr. Tyler's Journey into Medicine01:34 Life on the Farm and Early Influences03:03 Medical Training and Early Career04:34 Challenges and Rewards of Rural Pediatrics15:09 Community Engagement and Initiatives24:24 HPV Vaccination Success24:41 Challenges of Accessing Specialists25:16 Project Echo and Telehealth Services27:22 Medicaid and Healthcare System Issues36:38 Adverse Childhood Experiences41:22 The Importance of Community and Family50:00 Loneliness and Mental Health53:09 Reflections on Rural MedicineDiabetes dialogues podcastDiabetes insights for HCPs. Dexcom's expert-led podcast, Diabetes Dialogues.Listen on: Apple Podcasts SpotifySupport the show

2025-07-18 Hosts Craig Lipset, Jane Myles, and Dr. Amir Kalali were joined by Shelly Barnes (UCB), Brittany Niland (Eli Lilly and Company) and Erica Coles Jacobsen (Konovo) for a discussion around healthcare providers (HCPs) and their involvement in clinical research. DTRA has partnered with Eli Lilly and Company and Konovo to better understand the sentiment of these HCPs around participating in clinical research. Using HCPs in trials can provide greater access for all patients, as well as continuing to build trust in research with providers. You can join TGIF-DTRA Sessions live on Friday's at 12:00 PM ET by checking out our LinkedIn. Follow the Decentralized Trials & Research Alliance (DTRA) on LinkedIn and X. Learn more about Membership options and our work at www.dtra.org.

Send us a message with this link, we would love to hear from you. Standard message rates may apply.PCOS affects approximately one in ten women of reproductive age, creating a cascade of symptoms from irregular periods to fertility challenges. This common hormonal and metabolic condition has implications for long-term health beyond just reproductive concerns, including increased risk for diabetes, heart disease, and mental health issues.• PCOS is characterized by elevated androgens and insulin resistance• Symptoms include irregular periods, acne, unwanted hair growth, and weight management challenges• Diagnosis requires meeting at least two of three Rotterdam criteria: irregular periods, high androgens, and polycystic ovaries• Having ovarian cysts alone does not mean someone has PCOS• PCOS increases risk for type 2 diabetes, high blood pressure, sleep apnea, and even endometrial cancer• First-line treatment involves lifestyle modifications including diet and regular exercise• Even modest weight loss (5-10%) can significantly improve symptoms• Mental health support is crucial as PCOS is associated with higher rates of anxiety and depression• Medication options include birth control pills, metformin, fertility medications, and anti-androgen treatments• Free resources like the Ask PCOS app and online support groups can provide additional helpShare this episode with someone who might benefit from understanding PCOS better. Send us your thoughts at yourcheckuppod@gmail.com.Diabetes dialogues podcastDiabetes insights for HCPs. Dexcom's expert-led podcast, Diabetes Dialogues.Listen on: Apple Podcasts SpotifySupport the showSubscribe to Our Newsletter! Production and Content: Edward Delesky, MD & Nicole Aruffo, RNArtwork: Olivia Pawlowski

Send us a textIs everything you've heard about carbs, seed oils, and diabetes wrong? Dr. Westman and Bart Kay dig into the real science.

Even for those not on insulin, Continuous Glucose Monitoring (CGM) is transforming the way HCPs approach diabetes treatment. Cher Pastore, MS, RD, CDCES, BC-ADM and guest David Doriguzzi, a Physician Assistant in endocrinology and internal medicine explore how Dexcom G7 and Stelo are reshaping diabetes management for people with type 1 diabetes, type 2 diabetes, and prediabetes. Together, they break down how Dexcom's portfolio provides real-time glucose monitoring, reveals patterns invisible through traditional blood sugar monitoring, and inspire meaningful behavior change. David shares patient stories that demonstrate how CGM is helping individuals recognize how food, activity and medications impact their diabetes management. He also explains how CGM empowers providers to tailor diabetes education and medication strategies, especially in primary care settings with limited access to endocrinologists.  Whether you're managing type 1 diabetes, type 2 diabetes or on the journey to prevent it, this conversation showcases how diabetes technology like CGM can simplify treatment decisions, personalize care, and ultimately make an impact for both patients and providers.

Reporter Heerea Rikhraj sits down with Andrew Schultz, president of PatientPoint Precision, and David Paragamian, CEO of Health Monitor Network, to discuss how marketers can optimize POC marketing to bridge the gap between new knowledge information for HCPs and health equity considerations for patients.  Step into the future of health media at the MM+M Media Summit on October 30th, 2025 live in NYC! Join top voices in pharma marketing for a full day of forward-thinking discussions on AI, streaming, retail media, and more. Explore the latest in omnichannel strategy, personalization, media trust, and data privacy—all under one roof. Don't wait—use promo code PODCAST for $100 off your individual ticket. Click here to register! AI Deciphered is back—live in New York City this November 13th.Join leaders from brands, agencies, and platforms for a future-focused conversation on how AI is transforming media, marketing, and the retail experience. Ready to future-proof your strategy? Secure your spot now at aidecipheredsummit.com. Use code POD at check out for $100 your ticket! Check us out at: mmm-online.com Follow us: YouTube: @MMM-onlineTikTok: @MMMnewsInstagram: @MMMnewsonlineTwitter/X: @MMMnewsLinkedIn: MM+M To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.

In this special episode of the MM+M Podcast, we sit down with Dr. Osama Hashmi — dermatologist, cofounder and chief product officer at Impiricus — alongside practicing physician Dr. Bilal Ahmed — an interventional/structural cardiologist, cofounder and CSO of Lylah, a personalized microbiome therapeutics company — to explore how artificial intelligence is transforming the way healthcare professionals connect with pharmaceutical resources. We'll dive into how Impiricus and the life science companies it works with are building and leveraging the first and only AI-powered field force enhancement tool designed to streamline real-time communication between HCPs and pharma reps. From clinical decision support to on-demand access to drug information, this conversation unpacks how technology can bridge long-standing gaps in care delivery and engagement.Tune in for a forward-looking discussion on the evolving needs of clinicians, the role of AI in healthcare and how pharma can better support providers in delivering optimal patient outcomes.  Step into the future of health media at the MM+M Media Summit on October 30th, 2025 live in NYC! Join top voices in pharma marketing for a full day of forward-thinking discussions on AI, streaming, retail media, and more. Explore the latest in omnichannel strategy, personalization, media trust, and data privacy—all under one roof. Don't wait—use promo code PODCAST for $100 off your individual ticket. Click here to register! AI Deciphered is back—live in New York City this November 13th.Join leaders from brands, agencies, and platforms for a future-focused conversation on how AI is transforming media, marketing, and the retail experience. Ready to future-proof your strategy? Secure your spot now at aidecipheredsummit.com. Use code POD at check out for $100 your ticket! Check us out at: mmm-online.com Follow us: YouTube: @MMM-onlineTikTok: @MMMnewsInstagram: @MMMnewsonlineTwitter/X: @MMMnewsLinkedIn: MM+M To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.

In this special edition of the EMJ GOLD podcast, Isabel and Jade dive into the latest insights from recent contributors and EMJ's own data to uncover what healthcare professionals really want from medical affairs. They explore the growing challenges of engaging HCPs, question whether there's a gap between what HCPs say they want and what actually captures their attention and look ahead to what the future may hold. Tune in for expert insights from guests including Dr Donatello Crocetta, Bora Erdemli, Cécile Janssenswillen, Dr Natalia Barkalina and Dheepa Chari.

2025-06-27 Hosts Craig Lipset and Jane Myles shared about all things DIA Global Annual Meeting 2025. They shared more about key discussions and themes seen on the stage and in sessions and shared insights from attending the event this year. Additionally, Jane Myles shared more about her panel discussion on HCPs participating in research.You can join TGIF-DTRA Sessions live on LinkedIn Live on Friday's at 12:00 PM ET by checking out our LinkedIn. Follow the Decentralized Trials & Research Alliance (DTRA) on LinkedIn and X. Learn more about Membership options and our work at www.dtra.org.

In this episode, Dr Gideon Hirschfield meets with patient advocate Jess Schnur to discuss challenges related to the diagnosis and management of primary biliary cholangitis (PBC) to provide actionable strategies for healthcare professionals to incorporate into patient care, including:Disease concerns and frequently asked questions from a patient perspectiveManaging symptomsTreatment options and supportive careImportance of awareness and educationPresenters:Gideon Hirschfield, MA, MB BChir, FRCP, PhDLily and Terry Horner Chair in Autoimmune Liver Disease ResearchProfessor, Division of Gastroenterology and HepatologyUniversity of TorontoDirector, The Autoimmune and Rare Liver Disease ProgrammeDirector, Francis Family Liver ClinicToronto General Hospital, University Health NetworkOntario, CanadaJess N. Schnur, BSN-RNNational PBC Patient AdvocateAmerican Liver FoundationDonation Support Services CoordinatorLifeline of OhioColumbus, OhioTo learn more, see the programHear Me: Patient Perspectives on PBC

This discussion explores the dynamic shifts in healthcare media, emphasizing the critical need for omnichannel experiences to engage both patients and HCPs effectively. We delve into the transformative role of AI in media planning, highlighting how bespoke technological solutions are crucial for navigating the unique complexities of the healthcare landscape. We will examine how technology can empower media planners, ensuring that human expertise remains central in a data-driven world. Step into the future of health media at the MM+M Media Summit on October 30th, 2025 live in NYC! Join top voices in pharma marketing for a full day of forward-thinking discussions on AI, streaming, retail media, and more. Explore the latest in omnichannel strategy, personalization, media trust, and data privacy—all under one roof. Don't wait—use promo code PODCAST for $100 off your individual ticket. Click here to register! AI Deciphered is back—live in New York City this November 13th.Join leaders from brands, agencies, and platforms for a future-focused conversation on how AI is transforming media, marketing, and the retail experience. Ready to future-proof your strategy? Secure your spot now at aidecipheredsummit.com. Use code POD at check out for $100 your ticket! Check us out at: mmm-online.com Follow us: YouTube: @MMM-onlineTikTok: @MMMnewsInstagram: @MMMnewsonlineTwitter/X: @MMMnewsLinkedIn: MM+M To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.

In late 2024 I spoke with an academically trained cardiologist expert in cardiometabolic risk prevention and obesity medicine, educator, Dr. Eldad Einav, from Beverly Hills, CA about the ongoing controversy about the shortage and patient access to the exciting new weight loss treatments such as GLP1 agonists. He shared many practical, clinical insights and research that are important to revisit today for patients, physicians, and payers who are seeking to provide the best solutions and learn from some recent shortcomings.0:00 Highlight #1 - Distinguishing the quality of weight loss solutions1:26 Highlight #2 - Providing reliable 503B Facility source for patients w/ no access to GLP13:18 - Speaker Introduction6:14 - Why Dr. Einav decided to specialize in obesity / weight loss9:38 - Why should cardiologists focus on weight management - preventive care?11:58 - Not many cardiologists manage weight12:34 - Patient preferences to treat weight vs hypertension or cholesterol14:34 - Problem of maintaining long-term weight loss 15:00 Look AHEAD study - well-controlled lifestyle study of weight loss with 16:19 Drugs meeting newer targets of 15% or higher weight loss16:57 - Select Trial: weight loss reduces risk of heart attack, stroke by 20%19:07 - New drugs approaching efficacy of bariatric surgery 21:29 - 2024 Shortage and patient access to new GLP1 drugs23:11 - Specialty pharmacy compounding GLP controversy26:06 - What doctors should know about choosing compounded drug alternatives27:54 - What patients should know about choosing their weight loss drugs31:22 - Reality of types of compounded medications used by US hospitals32:11 - Removing the double-standard of compounded medications to improve patient access33:46 - Helpful resources to learn how to access the right weight-loss medication37:47 - Final Advice to Patients and HCPs to make better decisions, consolidate fragmented care

This week on the podcast, the team are joined by omnichannel engagement expert Yacin Marzouki, who shares his strategies on how to make omnichannel work for both pharmaceutical companies and healthcare professionals.  Together, Yacin and Jade sit down in the studio to explore what it takes to harmonise omnichannel across an organisation, why content activation is still a major hurdle, how to make sure messaging truly resonates with HCPs and much more. Expect practical insights on operational excellence, the evolving role of AI and a fresh perspective on what success looks like across a product's lifecycle.  A little more on EMJ GOLD's guest…  Yacin Marzouki is a global omnichannel engagement lead on a mission to disrupt the industry's approach to omnichannel. Within the pharmaceutical sector, he specialises in shaping seamless customer journeys, driving content activation and aligning global strategies with local execution. Yacin is dedicated to transforming brand plans into meaningful, measurable customer engagements, and is passionate about building high-performing, collaborative teams that deliver real impact. 

Christine Lee, Head of Health Strategy and Partnerships at AnalyticsIQ, focuses on helping healthcare brands and pharmaceutical companies better understand and engage with healthcare providers by taking into account data beyond their professional lives. This data-driven Provider as a Person approach analyzes the healthcare professional's personal characteristics, outside interests, decision-making style, and preferred method of communication. The goal is to foster more meaningful relationships with providers, address provider burnout, and improve patient outcomes.   Christine explains, "We're coming into play here in supporting healthcare brands and better understanding the providers as people. As I mentioned, we're a people-based data company. I'd say that in an era where data is abundant and there is no shortage of health data being gathered and analyzed. So, you've got a lot of data assets out there that are coming from clinical trials, your real-world evidence, claims data, your electronic health records, all of which give insight into the aspects of a provider from a clinical setting. Traditionally, healthcare providers have been viewed primarily through the lens of their professional lives, their specialties, their role in patient care, prescription-writing behaviors, and even their affiliations. And these are super important factors. We do see those truly as table stakes, but they paint an incomplete picture."   "Providers, like patients, have unique lives, needs, and preferences, which really shape how they interact with the work they do and the brands they seek to engage with. The industry is really recognizing these nuances, which presents a unique opportunity for healthcare brands to acknowledge the complexity of the providers' lives beyond what you could say are their white coat moments, and differentiate their message. And so this can dig into driving more meaningful engagement. And for us here at AnalyticsIQ, we're focused on helping to understand healthcare providers, or HCPs, more broadly, and understanding some of their personal characteristics. So, the data we're bringing to the table to complement all the other data in the ecosystem will be things like considering their work-life balance." #AnalyticsIQ #HealthcareData #HealthcareAnalytics #HealthTech #HCPengagement #PatientExperience #ValueBasedCare #PersonalizedCare #HealthEquity #SDOH #HealthcarePrivacy #PatientData analytics-iq.com Download the transcript here

Christine Lee, Head of Health Strategy and Partnerships at AnalyticsIQ, focuses on helping healthcare brands and pharmaceutical companies better understand and engage with healthcare providers by taking into account data beyond their professional lives. This data-driven Provider as a Person approach analyzes the healthcare professional's personal characteristics, outside interests, decision-making style, and preferred method of communication. The goal is to foster more meaningful relationships with providers, address provider burnout, and improve patient outcomes.   Christine explains, "We're coming into play here in supporting healthcare brands and better understanding the providers as people. As I mentioned, we're a people-based data company. I'd say that in an era where data is abundant and there is no shortage of health data being gathered and analyzed. So, you've got a lot of data assets out there that are coming from clinical trials, your real-world evidence, claims data, your electronic health records, all of which give insight into the aspects of a provider from a clinical setting. Traditionally, healthcare providers have been viewed primarily through the lens of their professional lives, their specialties, their role in patient care, prescription-writing behaviors, and even their affiliations. And these are super important factors. We do see those truly as table stakes, but they paint an incomplete picture."   "Providers, like patients, have unique lives, needs, and preferences, which really shape how they interact with the work they do and the brands they seek to engage with. The industry is really recognizing these nuances, which presents a unique opportunity for healthcare brands to acknowledge the complexity of the providers' lives beyond what you could say are their white coat moments, and differentiate their message. And so this can dig into driving more meaningful engagement. And for us here at AnalyticsIQ, we're focused on helping to understand healthcare providers, or HCPs, more broadly, and understanding some of their personal characteristics. So, the data we're bringing to the table to complement all the other data in the ecosystem will be things like considering their work-life balance." #AnalyticsIQ #HealthcareData #HealthcareAnalytics #HealthTech #HCPengagement #PatientExperience #ValueBasedCare #PersonalizedCare #HealthEquity #SDOH #HealthcarePrivacy #PatientData analytics-iq.com Listen to the podcast here

Healthcare providers (HCPs) are busier and more overwhelmed than ever before, meaning the customer experience can no longer be an afterthought—it must be a strategic priority. In this Trending Health episode, Everly is joined by Raina Dhir & Colleen Lawlor to tackle a challenge every launch team faces—how to break through the noise and truly connect with HCPs at launch. Raina, Colleen, and Everly explore strategies for creating personalized, high-impact HCP experiences to truly enable leaders to differentiate their launches.To learn more about how we can help your team, reach out to colleen.lawlor@vynamic.com and raina.dhir@vynamic.com. Check out our recent Omnichannel Insight on our website for more information: From strategy to execution: Delivering an omnichannel transformation – Vynamic LLC Podcast Tags: healthcare, life sciences, product launch, product launch trends, life sciences trends, launch excellence, customer engagement, customer experience Panel –Everly Petruzzelli, Colleen Lawlor, Raina Dhir Research & Production – Julia Morrison, Adrea Cope, Everly Petruzzelli  Recording & Editing – Mike Liberto, Rachel Skonecki For additional discussion, please contact us at TrendingHealth.com.

MedPod Today: the podcast series where MedPage Today reporters share deeper insight into the week's biggest healthcare stories. This week, MedPage Today reporters discuss the fallout from major

Negotiating with High Conflict Personalities: A Transformative ApproachIn this enlightening episode of It's All Your Fault, hosts Megan Hunter and Bill Eddy from the High Conflict Institute welcome Michèle Huff, author of "The Transformative Negotiator: Changing the Way We Come to Agreement." Through her experience as a transactional lawyer and current executive director at UC Berkeley's Office of Business Contracts and Brand Protection, Huff shares insights that align perfectly with managing high conflict situations while maintaining humanity and connection.The conversation explores how Huff's unique approach to negotiation - emphasizing internal transformation and human connection - can be particularly effective when dealing with high conflict personalities. Drawing from Buddhist principles and years of experience in Silicon Valley, Huff explains how understanding oneself becomes crucial when facing challenging behaviors in negotiations. Bill and Megan connect these concepts to their extensive work with high conflict personalities, showing how transformative negotiation techniques can help manage difficult situations.The discussion delves into practical strategies for maintaining composure when faced with high conflict behaviors, including the use of "anchoring" techniques and mindful breathing. Particularly valuable is the exploration of how these methods can work even in high-stakes business environments where traditional aggressive negotiation tactics are common. The episode also addresses cultural differences in negotiation styles, offering insights into managing high conflict situations across cultural boundaries.Questions we answer in this episode:How do you maintain effectiveness when dealing with high conflict personalities?What techniques help keep negotiations productive when emotions run high?How can you recognize early warning signs of high conflict behavior in negotiations?When should you walk away from a negotiation?What role does self-awareness play in managing difficult negotiations?Key Takeaways:Understanding your own triggers helps manage high conflict situationsHuman connection can defuse potentially volatile negotiationsPhysical and emotional well-being directly impacts negotiation successSetting appropriate boundaries is crucial in high conflict situationsTransformative negotiation techniques work in both personal and professional contextsThis episode provides essential insights for anyone who deals with high conflict personalities in negotiations, from business professionals to mediators to individuals managing personal relationships. Huff's approach to transformative negotiation, combined with Bill and Megan's expertise in high conflict personalities, offers practical strategies for achieving better outcomes while maintaining professional boundaries and personal well-being.Links & Other NotesBOOKSThe Transformative Negotiator: Changing the Way We Come to Agreement (Revised & Updated Edition)Purchase on our website: https://www.unhookedmedia.com/stock/p/transformative-negotiator-fcgdxPurchase on AmazonGUEST MICHELE HUFF WEBSITEhttps://michelehuff.com/2nd-edition-book/ARTICLESRead Michele's blogOUR WEBSITE: https://www.highconflictinstitute.com/Submit a Question for Bill and MeganAll of our books can be found in our online store or anywhere books are sold, including as e-books.You can also find these show notes at our site as well.Note: We are not diagnosing anyone in our discussions, merely discussing general patterns of behavior. Nor are we providing legal of therapeutic advice. Please seek the assistance of your local professionals to seek help. (00:00) - Welcome to It's All Your Fault (01:43) - Michèle Huff (05:27) - Her Background (11:28) - Book's Title (13:15) - Soft Skills in Negotiations (17:37) - Transferring Skills (20:55) - Mistakes in Negotiating (25:51) - Negotiating with HCPs (34:28) - Caring and Authenticity (40:38) - Finding Your Anchors and Keeping Deadlines at Bay (45:53) - Resistance (50:27) - Dedication (54:13) - Wrap Up (55:00) - Reminders & Coming Next Week: Kara Rubenstein on DNA Surprises Learn more about our Conflict Influencer Class. Get started today!

In this episode, Dr Gideon Hirschfield meets with patient advocate Jess Schnur to discuss challenges related to the diagnosis and management of primary biliary cholangitis (PBC) to provide actionable strategies for healthcare professionals to incorporate into patient care, including:Disease concerns and frequently asked questions from a patient perspectiveManaging symptomsTreatment options and supportive careImportance of awareness and educationPresenters:Gideon Hirschfield, MA, MB BChir, FRCP, PhDLily and Terry Horner Chair in Autoimmune Liver Disease ResearchProfessor, Division of Gastroenterology and HepatologyUniversity of TorontoDirector, The Autoimmune and Rare Liver Disease ProgrammeDirector, Francis Family Liver ClinicToronto General Hospital, University Health NetworkOntario, CanadaJess N. Schnur, BSN-RNNational PBC Patient AdvocateAmerican Liver FoundationDonation Support Services CoordinatorLifeline of OhioColumbus, OhioTo learn more, see the program Hear Me: Patient Perspectives on PBC

Understanding Anger and High Conflict PersonalitiesBill Eddy and Megan Hunter, co-founders of the High Conflict Institute, dive deep into the complex relationship between anger and high conflict personalities. This illuminating episode explores why some people experience instant rage while others maintain better emotional control, particularly in challenging interpersonal situations.The Science Behind Anger ManagementRecent research from Ohio State University challenges common beliefs about anger management techniques. Contrary to popular advice, activities like venting or intense physical exercise may not effectively reduce anger. Instead, the key lies in lowering physiological arousal through specific calming techniques. Bill and Megan explore these findings while discussing the brain's role in emotional regulation, particularly focusing on the relationship between the amygdala and prefrontal cortex.Different Personalities, Different Anger PatternsThe episode provides valuable insights into how various personality types experience and express anger differently. Bill explains how people with different personality traits may process and display anger in distinct ways, from calculated responses to uncontrolled emotional outbursts. This understanding is crucial for developing effective interaction strategies.Connection and Anger ManagementBill and Megan discuss the surprising effectiveness of human connection in managing anger. Whether through eye contact, using someone's name, or engaging in group activities, the power of connection emerges as a key factor in de-escalating high conflict situations.Questions we answer in this episode:Why do some people go from calm to enraged so quickly?How do different personality types experience and express anger?What anger management techniques actually work?How does early childhood development affect adult anger patterns?What role does human connection play in managing anger?Key Takeaways:Not all traditional anger management techniques are effectiveDifferent personality types express anger in distinct waysHuman connection can be a powerful tool for de-escalating angerEarly childhood experiences significantly impact adult anger patternsUnderstanding anger triggers is crucial for better managementThis episode provides essential insights for anyone dealing with high conflict personalities or seeking to better understand anger management. Through research-backed discussion and practical examples, Bill and Megan offer valuable strategies for managing anger in both personal and professional contexts.Links & Other NotesBOOKSOur New World of Adult BulliesThe Archaeology of Mind: Neuroevolutionary Origins of Human EmotionsARTICLESA meta-analytic review of anger management activities that increase or decrease arousal: What fuels or douses rage?Breathe, don't vent: Turning down the heat is key to managing angerOUR NEWSLETTERGet our updates.SPEAKING ENGAGEMENTSInvite us to speak.OUR WEBSITE: https://www.highconflictinstitute.com/Submit a Question for Bill and MeganAll of our books can be found in our online store or anywhere books are sold, including as e-books.You can also find these show notes at our site as well.Note: We are not diagnosing anyone in our discussions, merely discussing general patterns of behavior. Nor are we providing legal of therapeutic advice. Please seek the assistance of your local professionals to seek help. (00:00) - Welcome to It's All Your Fault (01:37) - Catching Up (03:43) - Anger and Ways to Get Rid of It (07:12) - HCP Types and Anger (12:23) - Conscious vs. Unconscious (13:33) - Anger and the Brain (18:20) - Learning Self Restraint (19:54) - Study Highlights (21:23) - Difficult for HCPs (23:09) - More Research (30:59) - Archaelogy of the Mind (38:41) - Reminders & Coming Next Week: Being Assertive Learn more about our New Ways for Work for Leaders. Get started today!

Resources mentioned in this episode:E-ordering options that make it faster and easier for HCPs to order and alter patients' suppliesUOAA Resources LibraryAccess to Supplies with Medicare words of Advice from UOAA Advocacy teamThe Critical Need to Provide Ostomy Supplies Specific to Patient Need to ImproveLCD-Ostomy Supplies (L33828)UOAA non-medical switching of ostomy supplies campaignUOAA's Roadmap to establish outpatient ostomy services. About the Guest:Yelena Brusilovsky is the National Vice President of Sales for Edgepark and has been with the organization for 12 years. In her role, she leads three key teams: the urology and ostomy inside sales team, the diabetes sales team focused on endocrinologists and internal medicine providers, and the market access team responsible for managing Edgepark's relationships with contracted insurance payers. With extensive experience in healthcare sales and market access, Yelena is committed to improving patient access to essential medical supplies and fostering stronger collaboration between DMEs and healthcare professionals. Editing and post-production work for this episode was provided by The Podcast Consultant.

Resources mentioned in this episode:E-ordering options that make it faster and easier for HCPs to order and alter patients' suppliesUOAA Resources LibraryAccess to Supplies with Medicare words of Advice from UOAA Advocacy teamThe Critical Need to Provide Ostomy Supplies Specific to Patient Need to ImproveLCD-Ostomy Supplies (L33828)UOAA non-medical switching of ostomy supplies campaignUOAA's Roadmap to establish outpatient ostomy services. About the Guest:Yelena Brusilovsky is the National Vice President of Sales for Edgepark and has been with the organization for 12 years. In her role, she leads three key teams: the urology and ostomy inside sales team, the diabetes sales team focused on endocrinologists and internal medicine providers, and the market access team responsible for managing Edgepark's relationships with contracted insurance payers. With extensive experience in healthcare sales and market access, Yelena is committed to improving patient access to essential medical supplies and fostering stronger collaboration between DMEs and healthcare professionals. Editing and post-production work for this episode was provided by The Podcast Consultant.

Arielle Smith, the President of Life Science at Event Cadence, discusses the changes in the event technology landscape and the expectations of pharmaceutical companies and attendees for a hybrid approach, including participation in person and virtually. There is an increased demand for insight capturing and analytics to measure the return on investment in conferences and the time attendees spend there. The platform includes scheduling, appointment management, and lead generation with tools to encourage networking and interaction to enhance the event experience.   Arielle explains, "Medical conferences are held all over the world, as you know, and there's not always going to be a time where you can physically put boots on the ground and travel for them. So we're seeing a lot more of a hot tier point, a hybrid model approach to it where, let's say, the majority of the team will be in a meeting room face to face with some of their HCPs, but then even that HCP might decide to dial in their counterpart. Or if a pharmaceutical client is not able to participate in person for many different reasons, we're looping them in from a virtual perspective as well. And our platform can help coordinate all of that." "So there's a lot of talk in the industry about insight capturing and gathering and exactly how that can be done but how best to make it actionable. Many great platforms are spinning up recently that are meant for capturing recordings or recording a conversation like the one you and I are having now, but then using AI to transcribe it all. A lot of our accounts are playing with technology like that, and then our platform is being used to set those conversations up."  #EventCadence #MedicalConferences #ConferenceManagement #HybridConferences eventcadence.com Download the transcript here

Arielle Smith, the President of Life Science at Event Cadence, discusses the changes in the event technology landscape and the expectations of pharmaceutical companies and attendees for a hybrid approach, including participation in person and virtually. There is an increased demand for insight capturing and analytics to measure the return on investment in conferences and the time attendees spend there. The platform includes scheduling, appointment management, and lead generation with tools to encourage networking and interaction to enhance the event experience.   Arielle explains, "Medical conferences are held all over the world, as you know, and there's not always going to be a time where you can physically put boots on the ground and travel for them. So we're seeing a lot more of a hot tier point, a hybrid model approach to it where, let's say, the majority of the team will be in a meeting room face to face with some of their HCPs, but then even that HCP might decide to dial in their counterpart. Or if a pharmaceutical client is not able to participate in person for many different reasons, we're looping them in from a virtual perspective as well. And our platform can help coordinate all of that." "So there's a lot of talk in the industry about insight capturing and gathering and exactly how that can be done but how best to make it actionable. Many great platforms are spinning up recently that are meant for capturing recordings or recording a conversation like the one you and I are having now, but then using AI to transcribe it all. A lot of our accounts are playing with technology like that, and then our platform is being used to set those conversations up."  #EventCadence #MedicalConferences #ConferenceManagement #HybridConferences eventcadence.com Listen to the podcast here

This special episode of RealTalk MS is sponsored by EMD Serono and is only intended for a U.S. audience. EMD Serono is the healthcare business of Merck, KGaA, Darmstadt, Germany, in the United States and Canada. In this special episode of RealTalk MS, Dr. Mary Rensel and Amanda Montague join me to explore HCP (Healthcare Provider) burnout and patient empowerment; and we'll be taking a close look at how patients and their healthcare providers can work together to support one another. Dr. Mary Rensel is an Assistant Professor of Medicine at the Cleveland Clinic Lerner College of Medicine and Director of Pediatric Multiple Sclerosis and Wellness at the Mellen Center for Multiple Sclerosis at the Cleveland Clinic. Amanda Montague is a global thought leader and Chief Mission Officer at the Multiple Sclerosis Association of America. Amanda is also an active member of the MS in the 21st Century initiative, more commonly known as MS21. MS21 is a Merck KGaA, Darmstadt, Germany, initiative involving healthcare professionals, or HCPs, and patient advocates. To learn more about MS in the 21st Century, please visit www.msinthe21stcentury.com.

This emergency doc paid off $311,000 in less than one year! He worked like crazy and picked up shifts every chance he could get. He and his family lived like residents and poured everything they could into the loans. He credits his wife and all she sacrificed to making this huge accomplishment possible. They are now excited to have him significantly cut back on shifts and to buy a much needed car. For Finance 101 find out what the best paying hobby you can have is. Our sponsor for this episode is Sermo, the leading online community for healthcare professionals seeking to earn extra income. Sermo offers flexible, paid surveys that help shape the future of medicine, along with opportunities for professional collaboration and support within a trusted community. With over 1.5 million members, Sermo is where HCPs come together to share insights, advice, and support. Join now at https://www.whitecoatinvestor.com/sermo and earn $20 instantly by completing your first two-question survey. The White Coat Investor has been helping doctors with their money since 2011. Our free financial planning resource covers a variety of topics from doctor mortgage loans and refinancing medical school loans to physician disability insurance and malpractice insurance. Learn about loan refinancing or consolidation, explore new investment strategies, and discover loan programs specifically aimed at helping doctors. If you're a high-income professional and ready to get a "fair shake" on Wall Street, The White Coat Investor channel is for you! Be a Guest on The Milestones to Millionaire Podcast: https://www.whitecoatinvestor.com/milestones  Main Website: https://www.whitecoatinvestor.com  Student Loan Advice: https://studentloanadvice.com  YouTube: https://www.whitecoatinvestor.com/youtube  Facebook: https://www.facebook.com/thewhitecoatinvestor  Twitter: https://twitter.com/WCInvestor  Instagram: https://www.instagram.com/thewhitecoatinvestor  Subreddit: https://www.reddit.com/r/whitecoatinvestor  Online Courses: https://whitecoatinvestor.teachable.com  Newsletter: https://www.whitecoatinvestor.com/free-monthly-newsletter